Table 1.
Baseline profile of children in a therapeutic efficacy study in three sites, Sierra Leone, 2016.
| Characteristic | ASAQ |
AL | DP |
||
|---|---|---|---|---|---|
| Bo (n = 65) | Makeni (n = 63) | Kenema (n = 64) | Bo (n = 52) | Makeni (n = 51) | |
| Male, n (%) | 35(53.8) | 33(52.4) | 42(65.6) | 30(57.7) | 24(47.1) |
| Age (years) | |||||
| Mean (SD) | 2.5(1.2) | 2.4 (1.3) | 3.4(1.2) | 2.7(1.1) | 2.5(1.2) |
| Range | 0.5–4.9 | 0.5–4.8 | 0.5–4.9 | 0.6–4.5 | 0.6–4.8 |
| Temperature (°C) on day 0 | |||||
| Mean (SD) | 37.3 (0.8) | 38.8 (1) | 38.1(1) | 37.2(0.8) | 38.5(0.7) |
| Parasitaemia (per μL) on day 0 | |||||
| Geometric mean | 25 088 | 22 032 | 14 272 | 21 539 | 37 230 |
| Range | 526–341 625 | 530–161 857 | 612–144 533 | 575–314 739 | 638–200 000 |
SD: standard deviation, ASAQ: artesunate+amodiaquine, AL: artemether+lumefantrine, DP: dihydroartemisinin+piperaquine.